Join The CGT Circle in Leiden on 24 November

Join The CGT Circle in Leiden on 24 November for an afternoon of talks, discussion and networking with women working across cell and gene therapy, from research and regulatory affairs to therapy development.

Want to meet other women working in cell and gene therapy and hear about their experiences? 

On 24 November, NecstGen will host The CGT Circle at Mirai House in Leiden. Join for an afternoon of talks and a panel discussion, followed by time to catch up with familiar faces and meet someone new. 

The CGT Circle is a community by women, for women. You’re welcome whether you’re just starting out in CGT or have worked in the field for years. Come along with a colleague or on your own. 

This year’s speakers work across research, regulatory affairs and therapy development. You’ll hear from women whose experience spans academic labs and biotech companies, and have time afterwards to exchange experiences with others working in the field. 

Speakers lineup 

  • Chantal van Litsenburg, Head Regulatory Affairs Office, LUMC. 
  • Dora Hammerl, Co-Founder and VP R&D, Pan Cancer T.  
  • Margot Pont, VP Translational Development, Integra Therapeutics.  

Translation of Living Drugs: Lessons Learned in Cell Therapy.  

  • Marleen van Loenen, Executive Director, Head of Discovery, T-knife Therapeutics.  

Programme: 

15:30 – Arrival & Registration 
16:00 – Speaker Session 
17:00 – Panel Discussion 
From 17:30 – Networking 

When: Tuesday, 24 November 2026, 15:30–19:00 
Where: NecstGen, Mirai House, Leiden 

Take an afternoon to hear how others approach their work and get to know more women in CGT. 

Register here

The First Stages of CAR T Cell Therapy Development

The First Stages of CAR T Cell Therapy Development

Chimeric Antigen Receptor (CAR) T cell therapy represents a transformative approach in medicine, particularly in oncology. This method offers personalised treatment by harnessing a patient's immune system to target and eliminate (cancer) cells. These novel therapies...

Webinar LV Process for CAR T

Webinar LV Process for CAR T

Shifting from traditional, ad hoc methodologies to a structured, data-based development approach to create a scalable, GMP-ready process.

Ready to discuss your GMP path?

Our experts are only a message away to help you understand the impact of any choices and to inform decision-making.

We’d be happy to discuss and help you bring Cell and Gene Therapies to patients.

NecstGen Services

Cell Therapy Development & Manufacturing

Viral Vector Development & Manufacturing

Consultancy

About Us

NecstGen is a non-profit CDMO and Centre of Excellence for Cell and Gene Therapy located in a purpose-built GMP facility in Leiden, The Netherlands. Dedicated to the field of Cell and Gene Therapies, we provide expertise and capacity.

About Us

Partners

History

Facility

Ecosystem